#Ucugen breaking out of the ascending triangle.
- Trend continuation to 20.00 USD expected!
- Ocugen Inc. is a biopharmaceutical company focused on the development, development and commercialization therapies for eye diseases.
- Ocugen is developing a vaccine against COVID-19.
- Number of employees: 15 people.
- Trend continuation to 20.00 USD expected!
- Ocugen Inc. is a biopharmaceutical company focused on the development, development and commercialization therapies for eye diseases.
- Ocugen is developing a vaccine against COVID-19.
- Number of employees: 15 people.
Заявка отменена